Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122,113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab Combined With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Oesophageal Squamous Cell Carcinoma: Protocol for a Multicentre, Prospective, Randomized-Controlled, Phase III Clinical Study (Keystone-002).
Shang X, Zhang W, Zhao G, Liang F, Zhang C, Yue J, Duan X, Ma Z, Chen C, Pang Q, Zhang W, Liu L, Ren X, Meng B, Zhang P, Ma Y, Zhang L, Li H, Kang X, Li Y, Jiang H. Shang X, et al. Among authors: li y, li h. Front Oncol. 2022 Mar 31;12:831345. doi: 10.3389/fonc.2022.831345. eCollection 2022. Front Oncol. 2022. PMID: 35433421 Free PMC article.
CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596).
Tang H, Tan L, Shen Y, Wang H, Lin M, Feng M, Xu S, Guo W, Qian C, Liu T, Zeng Z, Hou Y, Yu Z, Jiang H, Li Z, Chen C, Lian C, Du M, Li H, Xie D, Yin J, Zhao N, Wang Q. Tang H, et al. Among authors: li z, li h. BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7. BMC Cancer. 2017. PMID: 28659128 Free PMC article. Clinical Trial.
Adjuvant radiotherapy, chemotherapy or surgery alone for high-risk histological node negative esophageal squamous cell carcinoma: Protocol for a multicenter prospective randomized controlled trial.
Guo X, Fang W, Li Z, Yu Z, Rong T, Fu J, Han Y, Tan L, Chen C, Liu S, Liao Y, Xiao G, Wei Y, Zhu C, Li H, Luo J, Xing W. Guo X, et al. Among authors: li z, li h. Thorac Cancer. 2018 Dec;9(12):1801-1806. doi: 10.1111/1759-7714.12882. Epub 2018 Oct 1. Thorac Cancer. 2018. PMID: 30276974 Free PMC article. Clinical Trial.
Three-field versus two-field lymphadenectomy in transthoracic oesophagectomy for oesophageal squamous cell carcinoma: short-term outcomes of a randomized clinical trial.
Li B, Hu H, Zhang Y, Zhang J, Miao L, Ma L, Luo X, Zhang Y, Ye T, Li H, Li Y, Shen L, Zhao K, Fan M, Zhu Z, Wang J, Xu J, Deng Y, Lu Q, Li H, Zhang Y, Pan Y, Liu S, Hu H, Shao L, Sun Y, Xiang J, Chen H. Li B, et al. Among authors: li y, li h. Br J Surg. 2020 May;107(6):647-654. doi: 10.1002/bjs.11497. Epub 2020 Feb 28. Br J Surg. 2020. PMID: 32108326 Clinical Trial.
Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang H, Tang H, Fang Y, Tan L, Yin J, Shen Y, Zeng Z, Zhu J, Hou Y, Du M, Jiao J, Jiang H, Gong L, Li Z, Liu J, Xie D, Li W, Lian C, Zhao Q, Chen C, Zheng B, Liao Y, Li K, Li H, Wu H, Dai L, Chen KN. Wang H, et al. Among authors: li z, li w, li h, li k. JAMA Surg. 2021 May 1;156(5):444-451. doi: 10.1001/jamasurg.2021.0133. JAMA Surg. 2021. PMID: 33729467 Free PMC article. Clinical Trial.
Safety and efficacy of neoadjuvant treatment with immune checkpoint inhibitors in esophageal cancer: real-world multicenter retrospective study in China.
Yang Y, Tan L, Hu J, Li Y, Mao Y, Tian Z, Zhang B, Ma J, Li H, Chen C, Chen K, Han Y, Chen L, Liu J, Yu B, Yu Z, Li Z; Esophageal Cancer Committee of Chinese Anti-Cancer Association. Yang Y, et al. Among authors: li y, li z, li h. Dis Esophagus. 2022 Nov 15;35(11):doac031. doi: 10.1093/dote/doac031. Dis Esophagus. 2022. PMID: 35649396
Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.
Qi WX, Wang X, Li C, Li S, Li H, Xu F, Chen J, Zhao S, Li H. Qi WX, et al. Among authors: li c, li s, li h. Thorac Cancer. 2023 Jun;14(17):1556-1566. doi: 10.1111/1759-7714.14898. Epub 2023 Apr 24. Thorac Cancer. 2023. PMID: 37089116 Free PMC article.
122,113 results
You have reached the last available page of results. Please see the User Guide for more information.